1. Home
  2. GRDN vs PRCT Comparison

GRDN vs PRCT Comparison

Compare GRDN & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc. Class A Common Stock

GRDN

Guardian Pharmacy Services Inc. Class A Common Stock

HOLD

Current Price

$29.35

Market Cap

1.7B

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$35.50

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
PRCT
Founded
2004
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
GRDN
PRCT
Price
$29.35
$35.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$32.00
$56.57
AVG Volume (30 Days)
351.5K
1.6M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$1,389,638,000.00
$299,907,000.00
Revenue This Year
$19.50
$48.34
Revenue Next Year
$0.48
$29.35
P/E Ratio
$105.18
N/A
Revenue Growth
18.68
50.07
52 Week Low
$17.78
$27.80
52 Week High
$37.43
$99.60

Technical Indicators

Market Signals
Indicator
GRDN
PRCT
Relative Strength Index (RSI) 56.79 62.39
Support Level $28.62 $29.04
Resistance Level $29.90 $32.93
Average True Range (ATR) 1.04 1.63
MACD -0.06 0.67
Stochastic Oscillator 62.26 96.29

Price Performance

Historical Comparison
GRDN
PRCT

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: